E

Emergent Biosolutions
D

EBS

8.09000
USD
0.03
(0.37%)
Market Closed
Volume
90,446
EPS
2
Div Yield
-
P/E
-2
Market Cap
438,350,065
OverviewSignalsIdeasNews
Related Instruments
    CBOE
    CBOE
    -2.490
    (-1.28%)
    192.510 USD
    CME
    CME
    1.730
    (0.73%)
    238.570 USD
    G
    GNK
    0.090
    (0.66%)
    13.740 USD
    H
    HAL
    0.220
    (0.85%)
    25.975 USD
    ICE
    ICE
    2.095
    (1.41%)
    150.380 USD
    NDAQ
    NDAQ
    0.320
    (0.41%)
    77.690 USD
    N
    NG
    0.02500
    (0.76%)
    3.33500 USD
    O
    OFG
    0.935
    (2.28%)
    41.920 USD
    More
News

Title: Emergent Biosolutions

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.